In Focus this month:
Vaginal Ring Containing Dapivirine Offers Women Protection Against HIV
(From: New England Journal of Medicine)
A trial of the dapivirine vaginal ring showed an efficacy of up to 61 percent in women over age 25. The study showed that a vaginal ring containing an antiretroviral drug can provide protection against HIV-1 acquisition for women with higher rates of adherence.
Pre-Exposure Prophylaxis (PrEP) Is Feasible in Various Clinical Settings
(From: Current HIV/AIDS Reports)
A US-based comparison of the strengths and weaknesses of three settings for PrEP delivery (a health maintenance organization, a clinic treating sexually transmitted infections, and a primary care practice) showed that PrEP can be successfully implemented in a variety of settings. The authors called for actions to streamline PrEP delivery at each type of setting.
Conditional Cash Transfers Can Reduce HIV Infection in Young South African Women
(From: AIDS and Behavior)
This study was the first randomized controlled trial to examine the impact of a conditional cash transfer intervention on HIV infection among young women in rural South Africa. The findings showed that such interventions, which address structural factors like poverty, have the potential to reduce HIV risk among young women in the region.